Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current HIV/AIDS Reports
Erschienen in: Current HIV/AIDS Reports 4/2021

20.05.2021 | Behavioral-Bio-Medical Interface (RJ DiClemente and JL Brown, Section Editors)

Interventions Addressing Depression and HIV-Related Outcomes in People with HIV

verfasst von: Noelle A. Mendez, Daniel Mayo, Steven A. Safren

Erschienen in: Current HIV/AIDS Reports | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

People with HIV (PWH) are more likely to experience depression than those without HIV. Depression is not only distressing and interfering in and of itself, but it is also consistently associated with non-adherence to antiretroviral treatment (ART). Accordingly, research and clinical priorities require updated knowledge about interventions that address depression in PWH.

Recent Findings

Twenty efficacy trials and nine pilot studies since a 2009 review emerged in the literature review search. Of these, 11 and 6 respectively had a depression-related inclusion criterion. The intervention strategies included individual psychotherapy (n=6), group therapy (n=6), telehealth (n=3), and antidepressant medication (n=5). Generally, these interventions demonstrated acute efficacy for improving depression symptoms in PWH, with some also addressing ART non-adherence. However, not all studies collected follow-up data. Furthermore, trials that addressed depression but did not specifically address non-adherence did not also show adherence improvements.

Summary

Existing interventions for depression have demonstrated efficacy in PWH, and these may have both positive mental and physical health outcomes. Future trials should measure and boost longer-term effects. It would be useful to incorporate adherence interventions into depression treatment to improve self-care behaviors and health outcomes.
Literatur
1.
Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP. Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study. AIDS Behav. 2011;15:1161–70.PubMedPubMedCentralCrossRef
2.
Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus–infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–8.PubMedCrossRef
3.
Do AN, Rosenberg ES, Sullivan PS, Beer L, Strine TW, Schulden JD, et al. Excess burden of depression among HIV-infected persons receiving medical care in the United States: data from the Medical Monitoring Project and the Behavioral Risk Factor Surveillance System. Zheng JC, editor. PLoS One. 2014;9:e92842.PubMedPubMedCentralCrossRef
4.
Gokhale RH, Weiser J, Sullivan PS, Luo Q, Shu F, Bradley H. Depression prevalence, antidepressant treatment status, and association with sustained HIV viral suppression among adults living with HIV in care in the United States, 2009–2014. AIDS Behav. 2019;23:3452–9.PubMedCrossRef
5.
6.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth ed. Arlington: American Psychiatric Association. 2013.
7.
Marks King R, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC, et al. Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDs. 2012;26:479–85.PubMedCentralCrossRef
8.
Tucker JS, Burnam MA, Sherbourne CD, Kung F-Y, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573–80.PubMedCrossRef
9.
Carrico AW, Riley ED, Johnson MO, Charlebois ED, Neilands TB, Remien RH, et al. Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization. J Acquir Immune Defic Syndr. 2011;56:146–50.PubMedPubMedCentralCrossRef
10.
Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70:539–45.PubMedCrossRef
11.
Sherr L, Clucas C, Harding R, Sibley E, Catalan J. HIV and depression – a systematic review of interventions. Psychol Health Med. 2011;16:493–527.PubMedCrossRef
12.
Safren SA, O’Cleirigh C, Tan JY, Raminani SR, Reilly LC, Otto MW, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1–10.PubMedPubMedCentralCrossRef
13.
Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80:404–15.PubMedPubMedCentralCrossRef
14.
Safren SA, Otto MW, Worth JL. Life-steps: applying cognitive behavioral therapy to HIV medication adherence. Cogn Behav Pract. 1999;6:332–41.CrossRef
15.•
Safren SA, Bedoya CA, O’Cleirigh C, Biello KB, Pinkston MM, Stein MD, et al. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial. Lancet HIV. 2016;3:e529–38 This study integrates depression treatment with adherence counseling (CBT-AD) to target both mental and physical health outcomes. This type of approach has important individual and public health implications.PubMedPubMedCentralCrossRef
16.
Blashill AJ, Safren SA, Wilhelm S, Jampel J, Taylor SW, O’Cleirigh C, et al. Cognitive behavioral therapy for body image and self-care (CBT-BISC) in sexual minority men living with HIV: a randomized controlled trial. Health Psychol. 2017;36:937–46.PubMedPubMedCentralCrossRef
17.
Simoni JM, Wiebe JS, Sauceda JA, Huh D, Sanchez G, Longoria V, et al. A preliminary RCT of CBT-AD for adherence and depression among HIV-positive Latinos on the U.S.-Mexico border: the Nuevo Día Study. AIDS Behav. 2013;17:2816–29.PubMedPubMedCentralCrossRef
18.
Ironson G, O’Cleirigh C, Leserman J, Stuetzle R, Fordiani J, Fletcher M, et al. Gender-specific effects of an augmented written emotional disclosure intervention on posttraumatic, depressive, and HIV-disease-related outcomes: a randomized, controlled trial. J Consult Clin Psychol. 2013;81:284–98.PubMedCrossRef
19.
Eller LS, Kirksey KM, Nicholas PK, Corless IB, Holzemer WL, Wantland DJ, et al. A randomized controlled trial of an HIV/AIDS Symptom Management Manual for depressive symptoms. AIDS Care. 2013;25:391–9.PubMedCrossRef
20.
Bateganya MH, Amanyeiwe U, Roxo U, Dong M. Impact of support groups for people living with HIV on clinical outcomes: a systematic review of the literature. J Acquir Immune Defic Syndr. 2015;68 Suppl 3:S368–74.PubMedCrossRef
21.
Gerst-Emerson K, Jayawardhana J. Loneliness as a public health issue: the impact of loneliness on health care utilization among older adults. Am J Public Health. 2015;105:1013–9.PubMedPubMedCentralCrossRef
22.
23.
Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. Okulicz JF, editor. PLoS One. 2013;8:e81355.PubMedPubMedCentralCrossRef
24.
Heckman TG, Sikkema KJ, Hansen N, Kochman A, Heh V, Neufeld S. A randomized clinical trial of a coping improvement group intervention for HIV-infected older adults. J Behav Med. Springer. 2011;34:102–11.PubMedCrossRef
25.
Gonzalez-Garcia M, Ferrer MJ, Borras X, Muñoz-Moreno JA, Miranda C, Puig J, et al. Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection. AIDS Behav. 2014;18:676–85.PubMedCrossRef
26.
Gayner B, Esplen MJ, DeRoche P, Wong J, Bishop S, Kavanagh L, et al. A randomized controlled trial of mindfulness-based stress reduction to manage affective symptoms and improve quality of life in gay men living with HIV. J Behav Med. 2012;35:272–85.PubMedCrossRef
27.•
Hecht FM, Moskowitz JT, Moran P, Epel ES, Bacchetti P, Acree M, et al. A randomized, controlled trial of mindfulness-based stress reduction in HIV infection. Brain Behav Immun. 2018;73:331–9 This group intervention showed short-term improvements in positive affect for those who received mindfulness-based stress reduction, as well as trends in depression improvements at one-year follow-up.PubMedPubMedCentralCrossRef
28.
Jalali F, Hasani A, Hashemi SF, Kimiaei SA, Babaei A. Cognitive group therapy based on schema-focused approach for reducing depression in prisoners living with HIV. Int J Offender Ther Comp Criminol. 2019;63:276–88.PubMedCrossRef
29.
Nakimuli-Mpungu E, Wamala K, Okello J, Alderman S, Odokonyero R, Mojtabai R, et al. Group support psychotherapy for depression treatment in people with HIV/AIDS in northern Uganda: a single-centre randomised controlled trial. Lancet HIV. 2015;2:e190–9.PubMedCrossRef
30.
Galea S, Ahern J, Nandi A, Tracy M, Beard J, Vlahov D. Urban neighborhood poverty and the incidence of depression in a population-based cohort study. Ann Epidemiol. 2007;17:171–9.PubMedPubMedCentralCrossRef
31.
Vockley M. The rise of telehealth:‘Triple Aim,’ innovative technology, and popular demand are spearheading new models of health and wellness care. Biomed Instrum Technol. 2015;49:306–20.PubMedCrossRef
32.
Heckman TG, Heckman BD, Anderson T, Lovejoy TI, Mohr D, Sutton M, et al. Supportive-expressive and coping group teletherapies for HIV-infected older adults: a randomized clinical trial. AIDS Behav. 2013;17:3034–44.PubMedCrossRef
33.•
Heckman TG, Heckman BD, Anderson T, Lovejoy TI, Markowitz JC, Shen Y, et al. Tele-interpersonal psychotherapy acutely reduces depressive symptoms in depressed HIV-infected rural persons: a randomized clinical trial. Behav Med. 2017;43:285–95 In light of COVID-19 and the move to remote platforms for many services, evaluating remote interventions is critical. This study found that remote psychotherapy can be distributed efficaciously and to populations that might otherwise not have access to these services.PubMedCrossRef
34.
Himelhoch S, Medoff D, Maxfield J, Dihmes S, Dixon L, Robinson C, et al. Telephone based cognitive behavioral therapy targeting major depression among urban dwelling, low income people living with HIV/Aids: Results of a randomized controlled trial. AIDS Behav. 2013;17:2756–64.PubMedCrossRef
35.•
Pence BW, Gaynes BN, Adams JL, Thielman NM, Heine AD, Mugavero MJ, et al. The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS. 2015;29:1975–86 In this study, antidepressants were effective in reducing depression symptoms in the short-term. This study also confirms that addressing depression alone is not sufficient for improving ART adherence.PubMedCrossRef
36.
37.
Hengartner MP. How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding. Ther Adv Psychopharmacol. 2020;10:204512532092169.CrossRef
38.
Tsai AC, Karasic DH, Hammer GP, Charlebois ED, Ragland K, Moss AR, et al. Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health. 2013;103:308–15.PubMedPubMedCentralCrossRef
39.
Tsai AC, Weiser SD, Petersen ML, Ragland K, Kushel MB, Bangsberg DR. A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. Arch Gen Psychiatry. 2010;67:1282–90.PubMedPubMedCentralCrossRef
40.
Coleman SM, Blashill AJ, Gandhi RT, Safren SA, Freudenreich O. Impact of integrated and measurement-based depression care: clinical experience in an HIV clinic. Psychosomatics. 2012;53:51–7.PubMedCrossRef
41.
Beshai S, Dobson KS, Bockting CL, Quigley L. Relapse and recurrence prevention in depression: current research and future prospects. Clin Psychol Rev. Elsevier. 2011;31:1349–60.PubMedCrossRef
42.
Frye V, Nandi V, Egan J, Cerda M, Greene E, Van Tieu H, et al. Sexual orientation- and race-based discrimination and sexual HIV risk behavior among urban MSM. AIDS Behav. 2015;19:257–69.PubMedPubMedCentralCrossRef
43.
Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest. 2006;130:1326–33.PubMedCrossRef
44.
Safren SA, Harkness A, Lee JS, Rogers BG, Mendez NA, Magidson JF, et al. Addressing syndemics and self-care individuals with uncontrolled HIV: an open trial of a transdiagnostic treatment. AIDS Behav. 2020;24:3264–78.PubMedCrossRefPubMedCentral
45.
Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25:462–73.PubMedCrossRef
46.
Hochbaum G, Rosenstock I, Kegels S. Health belief model. Washington, DC: United States Public Health Service. 1952.
47.
Prochaska JO, DiClemente CC. The transtheoretical approach. In: Norcross JC, Goldfried MR, editors. Handbook of psychotherapy integration. Oxford: 2005;2:147–71.
48.•
Andersen LS, Magidson JF, O’Cleirigh C, Remmert JE, Kagee A, Leaver M, et al. A pilot study of a nurse-delivered cognitive behavioral therapy intervention (Ziphamandla) for adherence and depression in HIV in South Africa. J Health Psychol. 2018;23:776–87 This study provides a different modality for delivering depression treatment—having psychiatric nurses in an HIV clinic deliver the intervention. This could reduce barriers for those who might otherwise not receive mental health treatment.PubMedCrossRef
49.
Abas M, Nyamayaro P, Bere T, Saruchera E, Mothobi N, Simms V, et al. Feasibility and acceptability of a task-shifted intervention to enhance adherence to HIV medication and improve depression in people living with HIV in Zimbabwe, a low income country in Sub-Saharan Africa. AIDS Behav. 2018;22:86–101.PubMedCrossRef
50.
Tull MT, Berghoff CR, Bardeen JR, Schoenleber M, Konkle-Parker DJ. An initial open trial of a brief behavioral activation treatment for depression and medication adherence in HIV-infected patients. Behav Modif. 2018;42:196–209.PubMedCrossRef
51.
Kraaij V, van Emmerik A, Garnefski N, Schroevers MJ, Lo-Fo-Wong D, van Empelen P, et al. Effects of a cognitive behavioral self-help program and a computerized structured writing intervention on depressed mood for HIV-infected people: a pilot randomized controlled trial. Patient Educ Couns. 2010;80:200–4.PubMedCrossRef
52.
Petersen I, Hanass Hancock J, Bhana A, Govender K. A group-based counselling intervention for depression comorbid with HIV/AIDS using a task shifting approach in South Africa: a randomized controlled pilot study. J Affect Disord. 2014;158:78–84.PubMedCrossRef
53.
Dwight-Johnson M, Aisenberg E, Golinelli D, Hong S, O’Brien M, Ludman E. Telephone-based cognitive-behavioral therapy for Latino patients living in rural areas: a randomized pilot study. Psychiatr Serv. 2011;62:936–42.PubMedPubMedCentralCrossRef
54.
Junkins A, Psaros C, Ott C, Azuero A, Lambert CC, Cropsey K, et al. Feasibility, acceptability, and preliminary impact of telemedicine-administered cognitive behavioral therapy for adherence and depression among African American women living with HIV in the rural South. J Health Psychol. 2020. Available from: https://​doi.​org/​10.​1177/​1359105320926526​.
55.
Brown JL, Vanable PA, Carey MP, Elin L. Computerized stress management training for HIV+ women: a pilot intervention study. AIDS Care. 2011;23:1525–32.PubMedCrossRef
56.
Mgbako O, Miller EH, Santoro AF, Remien RH, Shalev N, Olender S, et al. COVID-19, telemedicine, and patient empowerment in HIV care and research. AIDS Behav. Springer. 2020;24:1990–3.PubMedCrossRef
57.
Rogers BG, Coats CS, Adams E, Murphy M, Stewart C, Arnold T, et al. Development of telemedicine infrastructure at an LGBTQ+ clinic to support HIV prevention and care in response to COVID-19, Providence, RI. AIDS Behav. Springer. 2020;24:2743–7.PubMedCrossRefPubMedCentral
58.
Young SD, Schneider J. Clinical care, research, and telehealth services in the era of social distancing to mitigate COVID-19. AIDS Behav. Springer. 2020;24:2000–2.PubMedCrossRefPubMedCentral
59.
Remien RH, Stirratt MJ, Nguyen N, Robbins RN, Pala AN, Mellins CA. Mental health and HIV/AIDS: the need for an integrated response. AIDS. 2019;33:1411–20.PubMedCrossRef
Metadaten
Titel
Interventions Addressing Depression and HIV-Related Outcomes in People with HIV
verfasst von
Noelle A. Mendez
Daniel Mayo
Steven A. Safren
Publikationsdatum
20.05.2021
Verlag
Springer US
Erschienen in
Current HIV/AIDS Reports / Ausgabe 4/2021
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-021-00559-w

Weitere Artikel der Ausgabe 4/2021

Current HIV/AIDS Reports 4/2021 Zur Ausgabe

Implementation Science (E Geng, Section Editor)

Novel Longitudinal Methods for Assessing Retention in Care: a Synthetic Review

Co-infections and Comorbidity (D Bhattacharya, Section Editor)

HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies

Behavioral-Bio-Medical Interface (RJ DiClemente and JL Brown, Section Editors)

Application of the Consolidated Framework for Implementation Research to Facilitate Violence Screening in HIV Care Settings: a Review of the Literature

Behavioral-Bio-Medical Interface (RJ DiClemente and JL Brown, Section Editors)

Approaches to Promoting Linkage to and Retention in HIV Care in the United States: a Scoping Review

Co-infections and Comorbidity (D Bhattacharya, Section Editor)

Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations

Implementation Science (E Geng, Section Editor)

Strategies for Successful Clinical Trial Recruitment of People Living with HIV in Low- and Middle-Income Countries: Lessons Learned and Implementation Implications from the Nigeria Renal Risk Reduction (R3) Trial

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise